Related Experiment Video

Updated: May 17, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

Oncogenic potential of cyclin kinase subunit-2 in cholangiocarcinoma

Dong-Yan Shen1, Yi-Hong Zhan, Qian-Ming Wang

  • 1Center for Laboratory, The First Affiliated Hospital of Xiamen University, Xiamen, China.

Liver International : Official Journal of the International Association for the Study of the Liver
|November 6, 2012
PubMed
Abstract

Insights

Cyclin kinase subunit-2 (Cks2) is elevated in cholangiocarcinoma, promoting cancer growth and chemotherapy resistance. Its inhibition halts tumor progression and induces apoptosis, suggesting Cks2 as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Cyclin kinase subunit-2 (Cks2) is crucial for cell cycle regulation in meiosis and mitosis.
  • Abnormal Cks2 expression is linked to various cancers, but its role in cholangiocarcinoma is not fully understood.

Purpose of the Study:

  • To investigate Cks2 expression levels in cholangiocarcinoma.
  • To elucidate the role and underlying mechanisms of Cks2 in cholangiocarcinoma development.

Main Methods:

  • Immunostaining and RT-PCR were used to assess Cks2 expression.
  • In vitro and in vivo assays (MTT, colony formation, xenografts) evaluated Cks2 function.
  • Flow cytometry and Western blotting analyzed cell cycle and apoptosis pathways.

Main Results:

  • Cks2 was significantly overexpressed in cholangiocarcinoma tissues, correlating with poor differentiation, elevated CA19-9, and worse prognosis.
  • Cks2 downregulation suppressed tumor cell proliferation, colony formation, and xenograft growth, while increasing chemosensitivity.
  • Cks2 knockdown induced G2/M cell cycle arrest and apoptosis via the mitochondrial pathway involving Cyclin A, Cyclin B1, and Bax.

Conclusions:

  • Cks2 is an independent prognostic marker for cholangiocarcinoma patients.
  • Cks2 promotes cholangiocarcinoma carcinogenesis by facilitating cell cycle progression and apoptosis.
  • Targeting Cks2 may offer a therapeutic strategy for cholangiocarcinoma.

More Related Videos

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.